A typical protocol involves daily or near-daily subcutaneous injections during an active cycle, followed by a transition to oral NMN supplementation (typically 250 to 500 mg/day) during the maintenance phase
GLP-1 medicines such as semaglutide are generally stopped before pregnancy because human pregnancy data remain limited and product labels advise against use while pregnant
Whether you choose compounded semaglutide, tirzepatide, or a microdose protocol, pairing medication with your genetic insights and working closely with your provider on behavior change and monitoring sets you up for better long-term weight stability and reduced rebound risk
Taking the Next Step If youve felt stuck between diet culture extremes and pharmaceutical fasttracks, the benefits of microdosing semaglutide offer a middle pathone that respects your hormones, mental health, and longterm goals
, , , , , , ,
PubChem Compound Summary for CID 10169788, Fequesetide